OMAHA, NE - January 22, 2026 - PRESSADVANTAGE - Modern Vision Solutions has announced the publication of a new article, ...

XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the root ...

Demodex blepharitis is a highly prevalent, yet often undiagnosed eyelid disease that impacts approximately 25 million eye care patients in the U.S. “We know that many patients struggle with eyelid ...

Interested parties may access the webcast here or at the events section of the Tarsus website. A replay will be available for a limited time at the same address. About TP-03TP-03 (lotilaner ophthalmic ...

Approximately 25 million eye care patients in the U.S. suffer from Demodex blepharitis, an eyelid disease characterized by inflammation, redness, and ocular irritation. 1-2 Demodex blepharitis is ...

Unique and memorable campaign intended to educate consumers about Demodex blepharitis and XDEMVY, the first and only FDA approved solution for the disease Demodex blepharitis impacts approximately 25 ...

Xdemvy is an eye drop prescribed for adults to treat Demodex blepharitis, an eyelid condition caused by mites. The recommended dosage is 1 drop in each eye twice per day for 6 weeks. While some people ...

AJMC®: Does the prevalence of Demodex blepharitis found by Trattler and colleagues 1 match what you see in clinical practice? BRUJIC: The prevalence of Demodex blepharitis is interesting. Prior to ...

An expert provides insights into the cost of misdiagnosed Demodex blepharitis and payer considerations for a potential cost-effective treatment. This is a video synopsis/summary of an Insights ...

Waking up with itchy eyelids might seem like a typical allergy symptom, but it could also be a sign of eye mites. Eye mites, or Demodex, are microscopic organisms that live at the base of your ...